Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
221.00    -1.00 (-0.45%)
Bid:
221.00
Ask:
232.00
Spread: 11.00 (4.977%)
Market Cap: £116.68m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Form 8 (OPD) Microgen plc

11 Jun 2014 09:34

ABERFORTH PARTNERS LLP - Form 8 (OPD) Microgen plc

ABERFORTH PARTNERS LLP - Form 8 (OPD) Microgen plc

PR Newswire

London, June 11

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Identity of the person whose positions/ Aberforth Partners LLP, ondealings are being disclosed: behalf of discretionary clients. (b) Owner or controller of interests and shortpositions disclosed, if different from 1(a): The naming of nominee or vehicle companies isinsufficient (c) Name of offeror/offeree in relation to Microgen plcwhose relevant securities this form relates: Use a separate form for each offeror/offeree (d) If an exempt fund manager connected withan offeror/offeree, state this and specifyidentity of offeror/offeree: (e) Date position held/dealing undertaken: 26 May 2014 (f) Has the discloser previously disclosed, or Y/N - NOare they today disclosing, under the Code inrespect of any other party to this offer? If YES, specify which: 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE (a) Interests and short positions in the relevant securities of the offeror orofferee to which the disclosure relates following the dealing (if any) Class of relevant security: Ordinary Shares Interests Short positions Number % Number % (1) Relevant securities owned 15,777,814 21.18 0 0.0and/or controlled: (2) Derivatives (other thanoptions): (3) Options and agreements topurchase/sell: TOTAL: 15,777,814 21.18 0 0.0 Aberforth Partners LLP does not have discretion regarding voting decisions inrespect of 6,201,206 shares included in the total disclosed above All interests and all short positions should be disclosed. Details of any open derivative or option positions, or agreements to purchaseor sell relevant securities, should be given on a Supplemental Form 8 (OpenPositions). (b) Rights to subscribe for new securities (including directors' and otherexecutive options) Class of relevant security in N/Arelation to which subscription rightexists: Details, including nature of the N/Arights concerned and relevantpercentages: If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (a) Purchases and sales Class of relevant Purchase/sale Number of Price per unit security securities N/A- OpeningDisclosure (b) Derivatives transactions (other than options) Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position N/A (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry Optionrelevant description purchasing, securities price date moneysecurity e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. N/A (ii) Exercising Class of relevant Product Number of Exercise price per security description securities unit e.g. call option N/A (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing Details Price per unit security (if applicable) e.g. subscription, conversion N/A The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevant securities ofthe offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (asappropriate) for each additional class of relevant security dealt in. 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement orunderstanding, formal or informal, relating to relevant securities which maybe an inducement to deal or refrain from dealing entered into by the personmaking the disclosure and any party to the offer or any person acting inconcert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none" None (b) Agreements, arrangements or understandings relating to options orderivatives Details of any agreement, arrangement or understanding, formal or informal,between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevantsecurities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? Y/N NO Date of disclosure: 27 May 2014 (amended 11 June 2014) Contact name: David Holland, for Aberforth Partners LLP Telephone number: 0131 220 0733 Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel atmonitoring@disclosure.org.uk . The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's dealing disclosurerequirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Date   Source Headline
2nd Apr 201912:12 pmRNSChange of Name to Aptitude Software Group plc
1st Apr 201911:04 amRNSTotal Voting Rights
27th Mar 20197:00 amRNSCorrection - Dividend Payment Schedule
26th Mar 20197:00 amRNSBLOCK LISTING 6-MONTHLY RETURN
25th Mar 20197:01 amRNSStrategic Update
25th Mar 20197:00 amRNSFinal Results
12th Mar 20197:00 amRNSNotice of Preliminary Results
1st Feb 20197:00 amRNSTotal Voting Rights
18th Jan 20192:12 pmRNSHolding(s) in Company
17th Jan 20197:00 amRNSTrading Update and Notice of Results
6th Dec 20185:13 pmRNSHolding(s) in Company
3rd Dec 201812:00 pmRNSTotal Voting Rights
30th Oct 20187:00 amRNSTrading Update
27th Sep 20182:54 pmRNSBlock Listing Six Monthly Return
5th Sep 201811:58 amRNSHolding(s) in Company
4th Sep 20184:29 pmRNSBlock Listing Application
31st Aug 201810:17 amRNSAward of Options
30th Jul 20188:21 amRNSHolding(s) in Company
25th Jul 201811:30 amRNSHolding(s) in Company
23rd Jul 20187:00 amRNSInterim Results
20th Jul 201811:19 amRNSHolding(s) in Company
17th Jul 20187:00 amRNSNotice of Interim Results
9th Jul 20187:00 amRNSTotal Voting Rights
3rd Jul 201812:21 pmRNSHolding(s) in Company
3rd Jul 201812:04 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSDisposal of Payments Business
2nd Jul 20189:50 amRNSDirector Declaration
18th Jun 20181:22 pmRNSHolding(s) in Company
15th Jun 201810:46 amRNSHolding(s) in Company
23rd Apr 20182:18 pmRNSResult of AGM
19th Apr 20184:07 pmRNSHolding(s) in Company
9th Mar 20189:06 amRNSTotal Voting Rights
7th Mar 20187:00 amRNSAudited Preliminary Results
21st Feb 20182:33 pmRNSDirector Declaration
19th Feb 20181:42 pmRNSHolding(s) in Company
12th Feb 20189:30 amRNSFWD fires starter gun on IFRS 17 implementation
1st Feb 20181:59 pmRNSTotal Voting Rights
18th Jan 20187:00 amRNSTrading Update and Notice of Results
27th Nov 20174:13 pmRNSDirector Declaration
18th Oct 201710:37 amRNSHolding(s) in Company
9th Oct 201712:42 pmRNSHolding(s) in Company
2nd Oct 201711:51 amRNSBlock Listing Return
2nd Oct 201711:49 amRNSTotal Voting Rights
25th Sep 20178:39 amRNSHolding(s) in Company
21st Sep 20178:30 amRNSHolding(s) in Company
18th Sep 201712:16 pmRNSHolding(s) in Company
14th Sep 20174:45 pmRNSHolding(s) in Company
13th Sep 201712:05 pmRNSHolding(s) in Company
12th Sep 20178:33 amRNSHolding(s) in Company
7th Sep 20178:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.